# The Utility of feNO in the Differential Diagnosis of Chronic Cough

> **NCT02479074** · PHASE4 · COMPLETED · sponsor: **Hull University Teaching Hospitals NHS Trust** · enrollment: 49 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** Montelukast (High FeNO group)
- **DRUG:** Prednisolon, Montelukast (High FeNO)
- **DRUG:** Montelukast (Low FeNO group)

## Key facts

- **NCT ID:** NCT02479074
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-02-10
- **Final completion:** 2017-03-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2019-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02479074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02479074, "The Utility of feNO in the Differential Diagnosis of Chronic Cough". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02479074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*